Becton Dickinson and Co vs Bit Digital Inc — how do they compare? Becton Dickinson and Co trades at $181.29 (market cap $48.93B), while Bit Digital Inc trades at $1.35 (market cap $453.60M). The key difference: Becton Dickinson and Co is far larger — about 107.9× Bit Digital Inc's market cap, and Becton Dickinson and Co pays a 2.34% dividend while Bit Digital Inc pays none. Which is the better fit depends on your goals.
| BDX | BTBT | |
|---|---|---|
Market Cap | $48.93B | $453.60M |
Sector | Health | Technology |
52-Week High | $185.39 | $4.22 |
52-Week Low | $138.62 | $1.23 |
Enterprise Value | $65.03B | $742.91M |
Dividend Yield | 2.34% | — |
Signals from Pluang's Aura AI — not financial advice
BDX (Becton, Dickinson and Company) trades at $176.86, down 0.12% on the day, with a bullish technical outlook supported by moving averages and strong earnings beats in recent quarters. The company reported Q3 2026 revenue of $5.0 billion, up 4.4% FX-neutral, and raised full-year guidance, though margins faced pressure. Analyst sentiment is mixed with a consensus price target of $183.00, while institutional ownership remains stable amid positive news on GLP-1 therapy expansions and dividend declarations.
The stock offers steady growth potential with a 2.7% dividend yield and consistent earnings outperformance, but risks include margin compression, regulatory recalls, and high valuation multiples. Near-term resistance at $180 and support at $173 will test bullish momentum, with the current price near the consensus target suggesting limited upside without further catalysts.
BTBT trades at $1.38 with a 1.1% daily gain, showing modest momentum despite a bearish technical signal from moving averages. The company reported revenue of $113.56M in 2025 but posted a significant net loss of $80.32M, with profitability metrics like ROE at -38.98% indicating financial strain. Analyst coverage remains limited but unanimously positive, with 2 buy ratings and no hold or sell recommendations. Recent news highlights upcoming Q2 2026 earnings and mixed price target discussions.
The outlook for BTBT is clouded by persistent losses and negative cash flow from operations, though financing activities provide liquidity. Investment opportunities hinge on a potential earnings turnaround, while risks include sustained unprofitability, competitive pressures, and reliance on external funding. The stock's low valuation multiples may attract value seekers, but caution is warranted given the fundamental challenges.
Trailing returns across standard periods
Latest headlines on both assets
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Interventional (largely the former Bard business) accounts for 23% of revenue. International revenue accounts for 44% of the company's business.
Read more on BDX →Bit Digital is a sustainability-focused digital asset production company. It primarily engages in Bitcoin mining and Ethereum staking while also providing high-performance computing (HPC) infrastructure for AI applications.
Read more on BTBT →